Le Lézard
Classified in: Health
Subjects: PSF, CPG

Judgment Rendered on Decree 2-2021 and Individuals Experiencing Homelessness


MONTREAL, Jan. 26, 2021 /CNW/ - Justice Chantal Masse of the Quebec Superior Court today suspended the application of Article 29 of Decree number 2-2021 establishing the curfew from 8 p.m. to 5 a.m. for people in a situation of homelessness.  The curfew therefore no longer applies to people who are homeless until February 5th, 2021. The Mobile Legal Clinic welcomes this decision, which protects the rights and well-being of people who are homeless in this time of pandemic. It would like to thank the law firm Trudel Johnston and Lespérance for representing the Mobile Legal Clinic pro bono.

As the judgment is subject to appeal, no further comment will be made at this time.

The full text of the judgement is available here.

THE MOBILE LEGAL CLINIC (MLC) in a non-profit founded in 2015 with the mission of promoting access to justice for individuals experiencing homelessness. The MLC provides an array of services, including access to comprehensive legal information, referrals and accompaniment, as well as assistance in regularizing legal debts. In these ways, the MLC contributes to these individuals' social reintegration.

TRUDEL JOHNSTON & LESPERANCE (TJL) is a law firm that has specialized in class actions and public interest litigation for the last twenty years. TJL has won more class action trials than any other law firm in Canada. It has also won several landmark cases, including important decisions of the Supreme Court of Canada.

SOURCE Trudel Johnston & Lespérance


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: